exelixis popular tagged News at allvoices.com

exelixis news

News tagged with “exelixis”. Found: 79 tagged news reports.
 

Your Search Returned 79 tagged news reports

 
Related Tags:

Dublin :: VA :: USA | 6 days ago

Credibility Credibility of 5

S&P Biotech Index  up  18% over the trailing 12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and companies that made waves

Tags:

New York City :: NY :: USA | 11 days ago

Credibility Credibility of 5

Zelboraf succeeded in a phase 3 trial's primary endpoint of extending progression-free survival. Of course, cobimetinib isn't all investors should think about regarding Exelixis: Cometriq will also be important. In the video below, health care

Tags:

Alexandria :: VA :: USA | 4 months ago

Credibility Credibility of 5

While the continuation of a trial would normally be a non-event -- we'll get the final data before the end of the year -- investors were clearly hoping that the drug would work so well that the trial would be stopped early...In the following video,

Tags:

Alexandria :: VA :: USA | 4 months ago

Credibility Credibility of 5

Biotechs Expecting Data The release of clinical trial data can be make-or-break moments for biotech companies...Exelixis' trials, dubbed Comet 1 and Comet 2, will measure Cometriq's ability to increase survival and decrease pain associated with bone

Tags:

Brussels :: Belgium | 5 months ago

Credibility Credibility of 5

For the quarter, Exelixis reported net product revenue from the sale of Cometriq, its only FDA-approved product to treat metastatic medullary thyroid cancer, of $4.3 million...Net loss for the quarter widened 35%, to $70.7 million from $52.2 million

Tags:

Alexandria :: VA :: USA | 9 months ago

Credibility Credibility of 5

While net losses widened to $67.1 million, or $0.36 per share, more than double the $32.8 million, or $0.20 per share loss reported in the same period in 2012, it was a penny-per-share better than the CapIQ estimates of $0.37 per share. The change in

Tags:

Alexandria :: VA :: USA | 11 months ago

Credibility Credibility of 5

This increase was due to positive data on its approved cystic fibrosis drug Kalydeco in conjunction with VX-661, its high-potential cystic fibrosis drug candidate currently in phase 2 clinical trials. This combination provides an improved lung

Tags:

Ascó :: Spain | 1 year ago

Credibility Credibility of 5

Investment Ideas Watch stocks you care about The single, easiest way to keep track of all the stocks that matter.....The American Society of Clinical Oncology annual meeting kicks off today. The scientific conference is the premier place for oncology

Tags:

Alexandria :: VA :: USA | 1 year ago

Credibility Credibility of 5

Every quarter, many money managers have to disclose what they've bought and sold, via "13F" filings. Their latest moves can shine a bright light on smart stock picks. Today let's look at Tocqueville Asset Management, a portfolio manager with a

Tags:

Mexico City :: Mexico | over 1 year ago

Credibility Credibility of 5

Feeding the bears Higher One was a promising trailblazer a few years ago, offering colleges and their coeds a cost-efficient way to manage financial aid and refunds. There have been a few hiccups along the way, and now growth has slowed dramatically.

Tags:



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.